ARCHIVES

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

New Tests Rule Out Theory On Polio Vaccine-AIDS Link.

October 6, 2000

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006